Thus, our study reveals an important role of IFN-I in reprograming tumor cell metabolism for antitumor immunity during CD47-SIRPα blockade and highlights the importance of tumor cell OXPHOS in immunotherapy. The gene discussed is CD47; the disease is neoplasm.